Table 1 Characteristics of clinical samples
Characteristic | Responder | Nonresponder | P Value | |
|---|---|---|---|---|
Number, n | 10 | 20 | Â | |
Gender, n (%) | Â | Â | 1.000 | |
Male | 10 (33%) | 20 (67%) | Â | |
Female | 0 (0%) | 0 (0%) | Â | |
Smoke, n (%) | Â | Â | 0.008 | |
No | 4 (40%) | 0 (0%) | Â | |
Yes | 6 (60%) | 20 (100%) | Â | |
Alcohol, n (%) | Â | Â | 0.045 | |
No | 7 (70%) | 5 (25%) | Â | |
Yes | 3 (30%) | 15 (75%) | Â | |
Weight, median (IQR) | 75 (62, 75) | 67 (65.6, 74) | 0.219 | |
BMI, mean ± SD | 23.544 (21.765, 24.212) | 23.128 (22.501, 24.102) | 0.947 | |
Triglycerides, mmol/L, mean ± SD | 2.25 (2.055, 2.6475) | 1.05 (0.905, 1.4425) | < 0.001 | |
Free fatty acid, mmol/L, mean ± SD | 0.399 ± 0.093506 | 0.43176 ± 0.13347 | 0.502 | |
T stage, n (%) | Â | Â | 0.861 | |
T2 | 2 (20%) | 4 (20%) | Â | |
T3 | 7 (70%) | 11 (55%) | Â | |
T4 | 1 (10%) | 5 (25%) | Â | |
N stage, n (%) | Â | Â | 0.563 | |
N0 | 1 (10%) | 4 (20%) | Â | |
N1 | 4 (40%) | 4 (20%) | Â | |
N2 | 5 (50%) | 12 (60%) | Â | |
M Stage, n (%) | Â | Â | 1.000 | |
M0 | 10 (33%) | 20 (67%) | Â | |
M1 | 0 (0%) | 0 (0%) | Â | |